EDIT
Editas Medicine Inc
Clinical-stage biotechnology company focused on CRISPR gene editing therapies
CUSIP: 28106W103HealthcareUS1 holder
Total Value
$10.16M
Total Shares
512.2K
Net Share Change
-221.2K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$10.16M512.2K shares
TRIM-221.2K(-30.2%)